EUVIMEDEUVIMED entdecken
Crossref

Glycyrrhizin and glycyrrhetinic acid: pharmacological potential for the treatment of viral respiratory infections

N. Alcántara-Martínez, U. Zendejas-Hernandez

Mexican journal of technology and engineering · 2022

DOI: 10.61767/mjte.001.2.0921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mexican journal of technology and engineering, 2022. Verfasst von N. Alcántara-Martínez und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycyrrhizinic acid (also known as glycyrrhizin) (GA) and its derivative 18-β-Glycyrrhetinic acid (18b-GA), which are isolated from the plant Glycyrryza glabra, show several therapeutic properties, including antioxidant, anti-inflammatory, and antiviral activity. These are therefore being evaluated for several medical proposes, among them the treatment of respiratory infections induced by viruses. The current review aimed to highlight the potential of GA and 18b-GA as efficient drugs. Both molecules have demonstrated antiviral activity against SARS-CoV-2, due to different mechanisms; for instance, blocking key enzymes for virus entry to the cell or by limiting virus replication. Those properties are well known from in vitro and animal assay research, however, reports of their effects on humans are scarce. One of the main challenges of using GA and 18b-GA as a drug is improving their solubility and permeability, as well as using therapeutic doses without toxic effects. Due to the biological properties of GA and 18b-GA, the dose and administration type are crucial to achieving a high local concentration and therefore a therapeutic effect.

Zitieren

APA

Alcántara-Martínez, N., & Zendejas-Hernandez, U. (2022). Glycyrrhizin and glycyrrhetinic acid: pharmacological potential for the treatment of viral respiratory infections. Mexican journal of technology and engineering. https://doi.org/10.61767/mjte.001.2.0921

Vancouver

Alcántara-Martínez N, Zendejas-Hernandez U. Glycyrrhizin and glycyrrhetinic acid: pharmacological potential for the treatment of viral respiratory infections. Mexican journal of technology and engineering. 2022. doi:10.61767/mjte.001.2.0921

BibTeX
@article{AlcntaraMartnez2022,
  author = {Alcántara-Martínez, N. and Zendejas-Hernandez, U.},
  title = {Glycyrrhizin and glycyrrhetinic acid: pharmacological potential for the treatment of viral respiratory infections},
  journal = {Mexican journal of technology and engineering},
  year = {2022},
  doi = {10.61767/mjte.001.2.0921}
}
Kostenlos starten →